303: Incidence and outcome of chronic graft-versus-host disease (cGVHD) after allogeneic stem cell transplant (SCT) using National Institute of Health (NIH) consensus criteria

cGVHD, defined as GVHD after day 100, is common, with an impact on morbidity and survival. The limited/extensive cGVHD classification is not reproducible or prognostic for late non-relapse mortality (NRM). Recently the NIH consensus criteria were proposed, but the ability of these criteria to predict outcome of various types of cGVHD is unknown.